Copyright
©The Author(s) 2021.
World J Orthop. Aug 18, 2021; 12(8): 584-603
Published online Aug 18, 2021. doi: 10.5312/wjo.v12.i8.584
Published online Aug 18, 2021. doi: 10.5312/wjo.v12.i8.584
Ref. | Construct | Subject | Sex (male/female) | Age at IP | Follow up | Diagnosis | No of patient with final spinal fusion | Comments, kind of complication analyzed | |
1 | Bess et al[15], 2010 | TGR | 140 | 71/59 | 6 | 5.0 | Neuromuscular (n = 52), idiopathic (n = 40), congenital (n = 24), and other (n = 24) | 50 | W, I, A, M |
2 | Du et al[16], 2020 | 167 | 69/98 | 7,2 | 10.7 | Idiopathic (n = 45), neuromuscular (n = 56), syndromic (n = 43), congenital (n = 21), other (n = 2) | 167 | Analyzed patients who had undergone a FF after growing-rod treatment, W, I, A, M | |
3 | Andras et al[13], 2015 | 36 | nd | 6.1 | 4.3 | Syndromal (n = 10), idiopathic (n = 11), congenital (n = 2), neuromuscular (n = 13) | nd | I, M | |
4 | Myung et al[17], 2014 | 159 | nd | 5 | 4.7 | Neuromuscular (n = 46), congenital (n = 42), idiopathic (n = 37), syndromal (n = 34) | nd | I | |
5 | Arandi et al[18], 2014 | 175 | 78/97 | 5.9 | 5.2 | Idiopathic (n = 69), syndromal (n = 62), neuromuscular (n = 44) | nd | I | |
6 | Liang et al[19], 2015 | 55 | 16/39 | 6.8 | 38.4 | Congenital (n = 28), idiopathic (n = 6), syndromal (n = 8), neuromuscular (n = 6) and miscellaneous disorders (n = 7) | 10 | W, I, A, M | |
7 | Ramirez et al[20], 2020 | 67 | 32/35 | 6 | 4.1 | Only non-ambulatory neuromuscular early-onset scoliosis | nd | W, I, M | |
8 | Yamaguchi et al[21], 2014 | 176 | nd | nd | 4.7 | Congenital (n = 48), neuromuscular (n = 42), syndromal (n = 37), idiopathic scoliosis (n = 32) and miscellaneous (n = 17) | nd | I | |
9 | Poe-Kochert et al[22], 2016 | 100 | 42/58 | 7 | 4.3 | Neuromuscular (n = 38), syndromic (n = 31), idiopathic (n = 22), congenital (n = 9) | 100 | Analyzed patients who had undergone a FF after growing-rod treatment; W, I | |
10 | Kabirian et al[23], 2014 | 379 | 177/202 | 6.3 | 5.3 | nd | nd | Only deep infection analyzed | |
11 | Hosseini et al[24], 2018 | 274 | 114/160 | 6.7 | 6.3 | Neuromuscular (n = 84), congenital (n = 43), syndromic (n = 89), idiopathic (n = 58) | nd | I | |
12 | Johnston et al[25], 2013 | 27 | nd | 5.3 | 4.5 | Neuromuscular (n = 6), idiopathic (n = 11), syndromic (n = 10) | 6 | Comparing with cast treatment, complications in total | |
13 | Bachabi et al[11], 2020 | 50 | nd | 5.5 | 8.3 | nd | nd | W, I, A, M | |
14 | Luhmann et al[14], 2017 | 18 | 18 | 7.7 | 7.4 | Idiopathic (n = 9), neuromuscular (n = 7), syndromic (n = 1), congenital (n = 1) | 17 | W, I, M | |
15 | Akbarnia et al[10], 2014 | 12 | 5 | 6.5 | 4.1 | Not given | nd | W, I, M | |
16 | Harris et al[8], 2020 | 353 | nd | 6 | 6.0 | Not given | nd | I, TGR -318 cases, 35 -VEPTR cases | |
17 | Helenius et al[9], 2018 | 214 | 94/120 | 5.6 | 6.0 | Neuromuscular (n = 68), congenital (n = 28), syndromic (n = 74), idiopathic (n = 44) | 49 | W, I, M TGR cases 198) MCGR cases 16 | |
18 | Gadepalli et al[26], 2011 | VEPTR | 26 | 16/10 | 7.58 | 7.0 | Congenital or infantile scoliosis (n = 12), neuromuscular scoliosis (n = 5), unspecified structural thoracic disorder (n = 7), Jeune syndrome (n = 2) | nd | W, I, M |
19 | Bachabi et al[11], 2020 | 22 | nd | 4.3 | 7.7 | nd | nd | W, I, M | |
20 | Crews et al[27], 2018 | 151 | 16/6 | 7.1 | 3+ | nd | nd | Only SSIs following VEPTR implant or revision surgeries were identified | |
21 | Murphy et al[28], 2016 | 25 | 12/13 | 5.7 | 4.5 | Congenital (n = 25) | nd | W, I, M | |
22 | Berger-Groch et al[29], 2020 | 13 | 7/6 | 2.2 | 7.6 | Congenital (n = 13) | nd | W, I, M | |
23 | Hasler et al[30], 2010 | 23 | 8/15 | 6.5 | 3.6 | Early onset idiopathic scoliosis (n = 1), neuromuscular (n = 11), post-thoracotomy scoliosis (n = 2), Sprengel deformity (n = 1), hyperkyphosis (n = 2), myopathy (n = 1), syndromic (n = 5) | nd | W, I, A, M | |
24 | Latalski et al[31], 2011 | 12 | nd | 5.25 | 2.5 | Congenital (n = 3), neuromuscular (n = 9) | 0 | W, I, A, M | |
25 | Hell et al[32], 2005 | 15 | 8/7 | 6 | nd | Congenital (n = 9), neuromuscular (n = 6) | 0 | W, I, M | |
26 | Garg et al[33], 2014 | 103 | 57/46 | 5.3 | Neuromuscular (n = 30), congenital (n = 44), syndromic (n = 18), idiopathic (n = 11) | Only wound complications following VEPTR implant or revision surgeries were identified | |||
27 | Waldhausen et al[34], 2016 | 65 | nd | 6.9 | 6.9 | Congenital (n = 23), neuromuscular (n = 12), syndromic (n = 14), idiopathic (n = 2), other (n = 14) | 28 | W, I, M | |
28 | Striano et al[35], 2019 | 166 | 6.81 | Neuromuscular (n = 61), syndromic (n = 38), congenital (n = 64), idiopathic (n = 3) | nd | Only wound complications following VEPTR implant or revision surgeries were identified | |||
29 | Lucas et al[36], 2013 | 54 | 21/33 | 7 | 2.0 | Neuromuscular (n = 19), congenital (n = 30), syndromic (n = 7), idiopathic (n = 3) | nd | W, I, A, M | |
30 | Garg et al[37], 2016 | 38 | 22/16 | 5.51 | 4.1 | Neuromuscular (n = 18), congenital (n = 13), syndromic (n = 5), idiopathic (n = 2) | nd | Only wound complications following VEPTR implant or revision surgeries were identified | |
31 | Subramanian et al[38], 2018 | MCGR | 31 | 15/16 | 7.7 | 3.9 | Neuromuscular (n = 4), syndromic (n = 19), idiopathic (n = 6), congenital (n = 2) | nd | W, I, A, M |
32 | Urbański et al[39], 2020 | 47 | 14/18 | 8.8 | 1-2.5 | Neuromuscular (n = 10), syndromic (n = 11), idiopathic (n = 20), congenital (n = 6) | 0 | W, I, A, M | |
33 | Akbarnia et al[10], 2014 | 12 | 5/7 | 6.8 | 2.5 | Neuromuscular (n = 4), syndromic (n = 4), idiopathic (n = 3), congenital (n = 1) | nd | I, M | |
34 | Studer et al[40], 2019 | 30 | 10/20 | 9.4 | 2.1 | Congenital (n = 11), neuromuscular (n = 10), syndromic (n = 4), idiopathic (n = 5) | nd | W, I, A | |
35 | Kwan et al[41], 2017 | 30 | 11/19 | 7.3 | 3.0 | Syndromal (n = 8), idiopathic (n = 8), congenital (n = 6), neuromuscular (n = 8) | 5 | W, I, A, | |
36 | Obid et al[42], 2020 | 22 | 4/18 | 9.5 | 4.0 | Idiopathic (n = 14), neurofbromatosis (n = 2), neuromuscular and syndromic (n = 6) | 9 | W, I, A, M | |
37 | Lampe et al[43], 2019 | 24 | 7/17 | 10.5 | 3.5 | Syndromal (n = 4), idiopathic (n = 9), congenital (n = 1), neuromuscular (n = 10) | nd | W, I, A, M | |
38 | Haapala et al[12], 2020 | 18 | 11/7 | 6.8 | 3.2 | Neuromuscular (n = 12) II, syndromic (n = 8) EOS two NFI (n = 2) | 5 | I, A, M | |
39 | Haapala et al[12], 2020 | Shilla | 13 | 8/5 | 6 | 4.0 | Neuromuscular (n = 11), syndromic (n = 2) | 4 | W, I, M |
40 | Andras et al[13], 2015 | Shilla | 36 | nd | 6.1 | 4.6 | Syndromal (n = 10), idiopathic (n = 11), congenital (n = 2), neuromuscular (n = 13) | nd | I, M |
41 | Nazareth et al[44], 2020 | Shilla | 20 | 10/10 | 5.7 | 5.2 | Syndromic (n = 9), neuromuscular (n = 5), idiopathic (n = 3), congenital (n = 3). | 7 | W, I, M |
42 | Miękisiak et al[45], 2019 | GGS | 57 | 13/44 | 9.8 | 2+ | Not given | nd | GGS – the same principle as Shilla. System made of Ti. W, I, A, M |
43 | McCarthy et al[46], 2014 | Shilla | 10 | 2/8 | 7.5 | 2.0 | Idiopathic (n = 3), congenital scoliosis (n = 1), syndromic (n = 2), neuromuscular scoliosis (n = 4) | nd | W, I |
44 | Luhmann et al[14], 2017 | Shilla | 18 | nd | 7.9 | 6.1 | Idiopathic (n = 8), neuromuscular (n = 7), syndromic (n = 3) | 15 and 3 implant removals | W, I, M |
45 | McCarthy et al[47], 2015 | Shilla | 40 | 17/23 | 6.11 | 5.0 | Idiopathic (n = 9), congenital (n = 1), neuromuscular (n = 16), syndromic (n = 14) | 15 and 3 Implant removals | W, I, A |
- Citation: Latalski M, Fatyga M, Sowa I, Wojciak M, Starobrat G, Danielewicz A. Complications in growth-friendly spinal surgeries for early-onset scoliosis: Literature review. World J Orthop 2021; 12(8): 584-603
- URL: https://www.wjgnet.com/2218-5836/full/v12/i8/584.htm
- DOI: https://dx.doi.org/10.5312/wjo.v12.i8.584